122 related articles for article (PubMed ID: 25846454)
1. Studies on the development of ¹⁶⁹Yb-brachytherapy seeds: New generation brachytherapy sources for the management of cancer.
Saxena SK; Kumar Y; Jagadeesan KC; Nuwad J; Bamankar YR; Dash A
Appl Radiat Isot; 2015 Jul; 101():75-82. PubMed ID: 25846454
[TBL] [Abstract][Full Text] [Related]
2. Implantation guidelines for 169 Yb seed interstitial treatments.
Piermattei A; Azario L; Montemaggi P
Phys Med Biol; 1995 Aug; 40(8):1331-8. PubMed ID: 7480116
[TBL] [Abstract][Full Text] [Related]
3. Comparison of high-dose rate prostate brachytherapy dose distributions with iridium-192, ytterbium-169, and thulium-170 sources.
Krishnamurthy D; Weinberg V; Cunha JA; Hsu IC; Pouliot J
Brachytherapy; 2011; 10(6):461-5. PubMed ID: 21397569
[TBL] [Abstract][Full Text] [Related]
4. Dosimetry of 169 Yb seed model X1267.
Piermattei A; Azario L; Rossi G; Soriani A; Arcovito G; Ragona R; Galelli M; Taccini G
Phys Med Biol; 1995 Aug; 40(8):1317-30. PubMed ID: 7480115
[TBL] [Abstract][Full Text] [Related]
5. A re-activation model for
Flynn RT; Smith BR; Adams QE; Patwardhan K; Graves SA; Hopfensperger KM
Med Phys; 2024 May; 51(5):3604-3618. PubMed ID: 38558460
[TBL] [Abstract][Full Text] [Related]
6. Brachytherapy at the nanoscale with protein functionalized and intrinsically radiolabeled [
Ghosh S; Patra S; Younis MH; Chakraborty A; Guleria A; Gupta SK; Singh K; Rakhshit S; Chakraborty S; Cai W; Chakravarty R
Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1558-1573. PubMed ID: 38270686
[TBL] [Abstract][Full Text] [Related]
7. Efficient
Flynn RT; Adams QE; Hopfensperger KM; Wu X; Xu W; Kim Y
Med Phys; 2019 Jul; 46(7):2935-2943. PubMed ID: 31054163
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the radiobiology of ytterbium-169 and iodine-125 permanent brachytherapy implants.
Lazarescu GR; Battista JJ
Phys Med Biol; 1997 Sep; 42(9):1727-36. PubMed ID: 9308079
[TBL] [Abstract][Full Text] [Related]
9. Broad-beam transmission data for new brachytherapy sources, Tm-170 and Yb-169.
Granero D; Pérez-Calatayud J; Ballester F; Bos AJ; Venselaar J
Radiat Prot Dosimetry; 2006; 118(1):11-5. PubMed ID: 16030058
[TBL] [Abstract][Full Text] [Related]
10. Dose distributions and dose rate constants for new ytterbium-169 brachytherapy seeds.
MacPherson MS; Battista JJ
Med Phys; 1995 Jan; 22(1):89-96. PubMed ID: 7715573
[TBL] [Abstract][Full Text] [Related]
11. A novel ytterbium-169 brachytherapy source and delivery system for use in conjunction with minimally invasive wedge resection of early-stage lung cancer.
Leonard KL; DiPetrillo TA; Munro JJ; Wazer DE
Brachytherapy; 2011; 10(2):163-9. PubMed ID: 20705525
[TBL] [Abstract][Full Text] [Related]
12. Development of a spherical (125)i-brachytherapy seed for its application in the treatment of eye and prostate cancer.
Saxena SK; Sharma SD; Kumar Y; Muthe KP; Dash A; Venkatesh M
Cancer Biother Radiopharm; 2008 Dec; 23(6):807-18. PubMed ID: 19111051
[TBL] [Abstract][Full Text] [Related]
13. Cross-section measurement of the 169 Tm p,n reaction for the production of the therapeutic radionuclide 169 Yb and comparison with its reactor-based generation.
Spahn I; Takács S; Shubin YN; Tárkányi F; Coenen HH; Qaim SM
Appl Radiat Isot; 2005 Aug; 63(2):235-9. PubMed ID: 15919210
[TBL] [Abstract][Full Text] [Related]
14. A dosimetric comparison of 169Yb versus 192Ir for HDR prostate brachytherapy.
Lymperopoulou G; Papagiannis P; Sakelliou L; Milickovic N; Giannouli S; Baltas D
Med Phys; 2005 Dec; 32(12):3832-42. PubMed ID: 16475783
[TBL] [Abstract][Full Text] [Related]
15. [Brachytherapy with palladium-103--a new way to deliver radiation therapy for localized prostatic cancer].
Aus G; Gunnarsson G; Nodbrant P
Lakartidningen; 2000 Aug; 97(32-33):3470-4. PubMed ID: 11037589
[TBL] [Abstract][Full Text] [Related]
16. Development of a new design (125)I-brachytherapy seed for its application in the treatment of eye and prostate cancer.
Saxena SK; Sharma SD; Dash A; Venkatesh M
Appl Radiat Isot; 2009; 67(7-8):1421-5. PubMed ID: 19282194
[TBL] [Abstract][Full Text] [Related]
17. Brachytherapy with Intratumoral Injections of Radiometal-Labeled Polymers That Thermoresponsively Self-Aggregate in Tumor Tissues.
Sano K; Kanada Y; Kanazaki K; Ding N; Ono M; Saji H
J Nucl Med; 2017 Sep; 58(9):1380-1385. PubMed ID: 28408533
[TBL] [Abstract][Full Text] [Related]
18. Internal radiotherapy techniques using radiolanthanide praseodymium-142: a review of production routes, brachytherapy, unsealed source therapy.
Bakht MK; Sadeghi M
Ann Nucl Med; 2011 Oct; 25(8):529-35. PubMed ID: 21720780
[TBL] [Abstract][Full Text] [Related]
19. [Radionuclides, technologies and quality control in brachytherapy].
Marchesi V; Gautier M; Villani N; Feuillade J; Dejean C
Cancer Radiother; 2013 Apr; 17(2):85-8. PubMed ID: 23474213
[TBL] [Abstract][Full Text] [Related]
20. Lu-177 preparation for radiotherapy application.
Park UJ; Lee JS; Choi KH; Nam SS; Yu KH
Appl Radiat Isot; 2016 Sep; 115():8-12. PubMed ID: 27295512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
